The development of novel anti-HIV drug targeting on Tat-specific CDK9 hidden cavity

○Kaori Asamitsu, Takashi Okamoto, Takatsugu Hirokawa

[2LBA-058] The development of novel anti-HIV drug targeting on Tat-specific CDK9 hidden cavity

○Kaori Asamitsu¹, Takashi Okamoto¹, Takatsugu Hirokawa^2,3 (1.Dept. of Neu. Sci., Grad. Sch. of Med., Nagoya City Univ., 2.Molprof, AIST, 3.Div. of Bio. Sci., Fac. of Med., Univ. of Tsukuba)

HIV transcription, CDK9, in silico screening, inhibitor

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

The 43rd Annual Meeting of the Molecular Biology Society of Japan

[2LBA-058] The development of novel anti-HIV drug targeting on Tat-specific CDK9 hidden cavity

Password